Physician profile
Mitchell Shecter
NPI 1912589110
$8,963.19
in general payments reported to CMS, 2019-2025
17 companies · $3,974 in 2025
The $3,974 reported for 2025 was more than what 95% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $396 · 2022: $1,069 · 2023: $2,130 · 2024: $1,394 · 2025: $3,974.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,437 · Travel and Lodging: $1,061.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,436.92 |
| Travel and Lodging | $1,060.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,772.50 | 2022-2025 | Propel, Nim Vital, Stealthstation S8 Platform |
| Inspire Medical Systems, INC. | $1,687.51 | 2023-2025 | Inspire |
| Integra Lifesciences Corporation | $1,316.43 | 2023-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Glaxosmithkline, LLC. | $947.10 | 2021-2025 | Nucala |
| Acclarent, INC | $810.95 | 2021-2024 | Acclarent Navwire, Relieva Spinplus, Acclarent Aera |
| Hologic Sales and Service, LLC | $429.84 | 2023-2025 | Coolseal Generator |
| Regeneron Healthcare Solutions, INC. | $428.95 | 2022-2025 | Dupixent |
| Genzyme Corporation | $409.48 | 2021-2025 | |
| Stryker Corporation | $271.04 | 2023-2025 | Scopis Ent, Xpress Ent Dilation System, 1788 |
| Alk-Abello, INC | $192.13 | 2022-2023 | Ragwitek, Grastek, Odactra |
| Aroa Biosurgery Incorporated | $176.51 | 2025 | |
| Acera Surgical, INC. | $126.61 | 2024 | Restrata Wound Matrix |
| Optinose US, INC. | $125.00 | 2025 | |
| Ambu INC. | $117.43 | 2022 | |
| Ars Pharmaceuticals Operations, INC. | $115.43 | 2025 | Neffy |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $18.85 | 2021 | |
| Cochlear Americas | $17.43 | 2024 | Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Osia Osi300 Implant, Baha |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mitchell Shecter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.